Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Heights Capital Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 24
Average round size
info
The average size of a deal this fund participated in
$45M
Portfolio companies 20
Rounds per year 0.86
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 13
Key employees Soon
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
Summary

The venture was found in North America in United States. The main department of described VC is located in the San Francisco.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Heights Capital Management performs on 26 percentage points more the average number of lead investments. The high activity for fund was in 2010. Considering the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2009.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Manufacturing, Energy. Among the most popular portfolio startups of the fund, we may highlight Amp'd Mobile, SinoHub, NovaDel Pharma Inc.

The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Heights Capital Management, startups are often financed by Steamboat Ventures, Universal Music Group, Redpoint. The meaningful sponsors for the fund in investment in the same round are Iroquois Capital, Ramius Capital, OrbiMed. In the next rounds fund is usually obtained by OrbiMed, J.P. Morgan Securities Inc., HealthCare Royalty Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Heights Capital Management:
Typical Co-investors
Heights Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Heights Capital Management:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Amber Sea Business Angels Club Community of Madrid, Madrid, Spain
Atresmedia Community of Madrid, Madrid, Spain
Beta Bayview -
BTM Japan, Tokyo
Business Incubators and Accelerators Company(BIAC Incubators) Ar Riyad, Riyadh, Saudi Arabia
Canopy Group Le Sueur, Minnesota, United States
CIBC Canada, Ontario, Toronto
CITIC Guoan Group Corporation Beijing, Beijing, China
FIBI Holding Israel, Tel Aviv, Tel Aviv District
Fukushima Bank Fukushima, Fukushima Prefecture, Japan
INTERWOOS Japan, Tokyo
ITIC: Industrial Technology Investment Corporation Taipei, Taiwan
Jwater Group Fukuoka, Fukuoka Prefecture, Japan
Kirlan Venture Capital Seattle, United States, Washington
Lam Research California, Fremont, United States
Magenta Venture Partners Herzliya, Israel, Tel Aviv
Medevice -
Mesa Ventures New York, New York, United States
Sabre Corporation Southlake, Texas, United States
WiSEED France, Midi-Pyrenees, Toulouse

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

League One Volleyball

$22M28 Sep 2022 -

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$20M01 Mar 2022 Chiyoda, Japan

Cullgen

Biotechnology
Pharmaceutical
$50M25 Feb 2021 Ohio, United States
News
Cullgen Closes $50 Million Series B Investment to Advance Targeted Protein Degraders and Novel E3 Ligands Platform

– Cullgen Inc. closed a $50m Series B financing (assuming exercise of warrant).
– The round was led by 3E Bioventures Capital, as well as Heights Capital Management (an affiliate of Susquehanna International Group), Octagon Capital, MSA Capital and South China Venture Capital.
– The financing will support the development of Cullgen’s technology platform and internal pipeline of targeted protein degraders in oncology and other diseases.
– Frank Yan, from 3E Bioventures, will be joining Cullgen’s board of directors.
– Cullgen is also pleased to announce that Frank Yan, from 3E Bioventures, will be joining Cullgen’s board of directors.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Heights Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 24
Average round size 45M
Rounds per year 0.86
Peak activity year 2022
Lead investments 1
Follow on index 0.17
Exits 13
Group Appearance index 0.88

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

League One Volleyball

$22M28 Sep 2022 -

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$20M01 Mar 2022 Chiyoda, Japan

Cullgen

Biotechnology
Pharmaceutical
$50M25 Feb 2021 Ohio, United States
Crunchbase icon

Content report

The following text will be sent to our editors: